Clinical Trials

40 enrolled

Phase 2 Active not recruiting

Carcinoma, Non-Small-Cell Lung

NCT03384914 2026-03-06

Vaccine to Prevent Recurrence in Patients With HER-2 Positive Breast Cancer

119 enrolled

Breast Neoplasms, Neoplasm, Residual, Breast Neoplasms, Male

NCT06719700 2026-03-03

Concurrent Chemoradiotherapy Combined With Toripalimab and Surufatinib in the Treatment of Limited-Stage Small Cell Lung Cancer

47 enrolled

Small Cell Lung Carcinoma

NCT02645149 2026-02-27

Match Mel

216 enrolled

Dermatologic

Melanoma

NCT04594187 2026-02-17

MelPORT

Phase NA Not yet recruiting

168 enrolled

Dermatologic

Melanoma

NCT07396116 2026-02-12

FUSION-02

28 enrolled

Sarcoma

Radiation Injuries, Sarcoma

NCT06943235 2026-02-11

Study of Probiotics Combined With Concurrent Hyperfractionated ChemoRadiotherapy and Adebrelimab Immunomaintenance in the Treatment of Limited-stage Small Cell Lung Cancer (LS-SCLC)

60 enrolled

Limited Stage Small Cell Lung Cancer

NCT07397442 2026-02-11

Short-Course Radiotherapy Combined With Chemotherapy and Immunotherapy in Mid-Low Locally Advanced Rectal Cancer

19 enrolled

Phase EARLY_PHASE1 Active not recruiting

Pathologic Complete Response, Rectal Neoplasms

NCT03387553 2026-02-09

HER2 Directed Dendritic Cell Vaccine During Neoadjuvant Therapy of HER2+Breast Cancer

31 enrolled

Breast Neoplasms, Breast Neoplasms, Male

NCT06610734 2026-02-09

SKY

202 enrolled

Small Cell Lung Cancer Extensive Stage

NCT06810609 2026-01-27

InDuRanS

176 enrolled

Carcinoma, Non-Small-Cell Lung

NCT05978193 2026-01-22

SCR-ESCC-01

100 enrolled

Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

NCT04821778 2026-01-21

Chemoradiotherapy in Esophageal or Esophagogastric Junction Cancer

2,000 enrolled

Esophageal Neoplasms

NCT04821843 2026-01-21

Neoadjuvant Treatment Modalities in Esophageal Cancer

2,000 enrolled

Esophageal Neoplasms

NCT04151940 2026-01-14

PET/CT Changes During Chemoimmunotherapy and Radiation Therapy in Patients With Stage IV Non-small Cell Lung Cancer

Phase NA Recruiting

80 enrolled

Phase NA Not yet recruiting

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT07337096 2026-01-13

Electro-Acupuncture in Lung cancER : EALER Study

424 enrolled

Carcinoma, Non-Small-Cell Lung

NCT06676449 2026-01-07

TDLN-sparing RT Plus Immunotherapy and Chemotherapy in Locally Advanced ESCC

432 enrolled

Esophageal Neoplasms

NCT07259473 2026-01-07

Pre-CATALIS

15 enrolled

Turcot syndrome

NCT05717166 2025-12-31

SABR-SYNC

180 enrolled

Tumor-Agnostic

Neoplasm Metastasis

NCT07305428 2025-12-26

Downstaging Unresectable Hepatocellular Carcinoma to Resectable Disease With Combined Immunotherapy and Stereotactic Beamed Radiotherapy: a Pilot Study

Phase NA Recruiting

30 enrolled

Carcinoma, Hepatocellular

NCT07293247 2025-12-22

A Study of Targeted Post-Surgery Radiation Therapy for Non-Small Cell Lung Cancer With Remaining Lymph Node Cancer After Treatment

164 enrolled

Carcinoma, Non-Small-Cell Lung

NCT07297030 2025-12-22

SIB-RT Combined With CAPOX and PD-1 for High-Risk Rectal Cancer

37 enrolled

Phase 2 Active not recruiting

Rectal Neoplasms

NCT03614949 2025-12-19

SBRT and Atezolizumab in the Management of Recurrent, Persistent, or Metastatic Cervical Cancer

21 enrolled

Gynecologic

Uterine Cervical Neoplasms

NCT06102057 2025-12-17

PACCELIO

110 enrolled

Phase 1 Not yet recruiting

Carcinoma, Non-Small-Cell Lung

NCT07257497 2025-12-02

Safety and Efficacy of Combining a Vitamin B6-Limited Diet With Immunotherapy in Solid Tumor Patients: A Clinical Study Protocol

20 enrolled

Other solid neoplasm

Solid Tumor Cancer

NCT07258147 2025-12-02

Safety and Efficacy of Radiotherapy Combined With Immunochemotherapy in Pre-treated SCLC Patients With Liver Metastases

30 enrolled

Lung Neoplasms

NCT07254858 2025-11-28

CISN-L

302 enrolled

Breast Neoplasms

NCT07250542 2025-11-26

A Clinical Study on the Efficacy and Safety of Fasudil Hydrochloride Combined With Immunotherapy in the Treatment of Metastatic Castration-resistant Prostate Cancer

30 enrolled

Genitourinary

Prostatic Neoplasms

NCT04454489 2025-11-19

Quad Shot Radiotherapy in Combination With Immune Checkpoint Inhibition

21 enrolled 18 charts

Squamous Cell Carcinoma of Head and Neck

NCT06804850 2025-11-19

Neoadjuvant Radiotherapy Plus Targeted Therapy and Immunotherapy vs. Targeted Therapy Plus Immunotherapy in Resectable HNSCC

Phase 2 Withdrawn

Phase NA Active not recruiting

Head and Neck Neoplasms

NCT06146920 2025-11-18

Use of Serial Plasma NGS as a New Efficacy Metric to Guide Immunotherapy Treatment Discontinuation

39 enrolled

DermatologicThoracic

Carcinoma, Non-Small-Cell Lung, Melanoma

NCT07231575 2025-11-18

Neoadjuvant SBRT and Tislelizumab (Immunotherapy) Plus Anlotinib for Resectable EGFR Wild-type NSCLC

39 enrolled

Neoadjuvant Immunotherapy

NCT03176173 2025-11-05

Radical RADiotherapy and Immunotherapy for Metastatic CAncer of the Lung (RRADICAL)

Phase NA Completed

45 enrolled 13 charts

Phase 1 Active not recruiting

Carcinoma, Non-Small-Cell Lung

NCT04926948 2025-10-22

Stereotactic Body Radiation Therapy With Immunotherapy for the Treatment of Mesothelioma

20 enrolled

Phase 3 Active not recruiting

Pleural Mesothelial Neoplasm

NCT03426891 2025-10-06

Pembrolizumab and Vorinostat Combined With Temozolomide for Newly Diagnosed Glioblastoma

Phase 1 Completed

21 enrolled 12 charts

CNS

Brain Neoplasms, Glioblastoma

NCT03721341 2025-09-18

SABR-COMET 10

204 enrolled

Tumor-Agnostic

Neoplasm Metastasis

NCT07154082 2025-09-04

Apatinib Mesylate and Camrelizumab Combined With TACE as Neoadjuvant Therapy for Hepatocellular Carcinoma

27 enrolled

Phase 3 Not yet recruiting

Carcinoma, Hepatocellular

NCT07135882 2025-08-22

PRIME-Lung

420 enrolled

Carcinoma, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT07130240 2025-08-19

Ivonescimab Combined With Paclitaxel and Cisplatin as Neoadjuvant Therapy Followed by Type A Hysterectomy in Stage IB2 and IIA1 Cervical Cancer

20 enrolled

Gynecologic

Uterine Cervical Neoplasms

NCT07118566 2025-08-12

Hyperthermia Combined With Immune Checkpoint Inhibitors in the Treatment of Advanced Gastrointestinal Malignancies With Liver Metastases

40 enrolled

Hyperthermia, Gastrointestinal Neoplasms

NCT03623646 2025-08-08

CITHARE

11 enrolled

Phase NA Active not recruiting

Squamous Cell Carcinoma of Head and Neck

NCT02276443 2025-08-01

Molecular Testing and Imaging in Improving Response in Patients With Stage I-III Triple-Negative Breast Cancer Receiving Chemotherapy MDACC Breast Moonshot Initiative

798 enrolled

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT07014202 2025-07-30

Consolidation Radiotherapy vs. Observation in Oligoresidual Advanced Non-Small Cell Lung Cancer After Chemo-Immunotherapy

224 enrolled

Carcinoma, Non-Small-Cell Lung

NCT06485947 2025-07-08

DBPilot

Phase 1 Recruiting

38 enrolled

CNS

Neuroblastoma

NCT06811844 2025-07-01

Two-cycle and Three-cycle Induction Therapy With Modified TPF Regimen Combined and Camrelizumab for LANPC

208 enrolled

Pathologic Complete Response, Nasopharyngeal Neoplasms

NCT06356584 2025-06-26

Fruquintinib Combined With Sintilimab ± Radiotherapy for Third-line Treatment of Colorectal Cancer With Liver Metastases

62 enrolled

Colorectal Neoplasms

NCT07034326 2025-06-24

Electroacupuncture Combined With Immune Checkpoint Inhibitors as Adjuvant Therapy After Surgery for Early-stage Non-small Cell Lung Cancer

Phase 2/3 Recruiting

405 enrolled

Carcinoma, Non-Small-Cell Lung

NCT07010120 2025-06-13

A Clinical Trial of Neoadjuvant Targeted Therapy, Immunotherapy, and Lysogenic HSV-Based Virotherapy in Resectable Head and Neck Squamous Cell Carcinoma

Phase 1/2 Recruiting

29 enrolled

Squamous Cell Carcinoma of Head and Neck

NCT07015489 2025-06-11

Concurrent Radiotherapy Following Induction Chemoimmunotherapy for Locally Advanced Esophageal Cancer